Research Progress of Aspirin Resistance in Diabetic Statue

谢昊,朱语眉,郝海平,郑啸,马思静,王广基
2014-01-01
Abstract:Aspirin is the gold standardof antiplatelet therapy.It plays a very important role in the prevention of cardiovascular disease. However,not all the patients can respond a consistent anti-aggregation effect after they take aspirin.Clinically,this phenomenon that therapeutic dose of can not prevent the cardiovascular events is called aspirin resistance(AR).A considerable portion of resistance patients also have diabetes or insulin resistance.Many diabetic patients take for primary prevention of cardiovascular disease,but the benefit is low.Aspirin can reduce the risk of cardiovascular events by 41%in non-diabetic patients.But the risk reduction in the subgroup with diabetes was only 10%.Although diabetes has been recognised as a high risk factor of resistance,the mechanism under the high diabetic prevalence in resistance patients is unclear.This paper will review the mechanisms of resistance in diabetic statue and explore methods to reverse it.
What problem does this paper attempt to address?